Skip to main content
. 2017 Apr 19;153(6):529–536. doi: 10.1001/jamadermatol.2017.0250

Table 3. Adverse Events in the Safety Population.

Variable Study Participants, No. (%) P Value
Propranolol Group
(n = 17)
Steroid Group
(n = 16)
Adverse events
Serious adverse event 0 0
Any adverse event 16 (94) 15 (94) >.99a
Known risks associated with drugsb
Bradycardia 0 0
Hypotension 5 (29) 1 (7) .18a
Hypoglycemia 0 0
Trouble breathing 0 0
Gastroesophageal reflux 0 0
Hypertension 7 (41) 7 (47) .75c
Growth disability 0 2 (13) .21a
a

Fisher exact test.

b

A complete list of adverse events is provided in Supplement 2.

c

χ2 Test.